Loading…
Reported covered position: SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001 - 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996)
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Increasing Access to Dental Insurance Act
Client: NATIONAL ASSOCIATION OF DENTAL PLANS · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
S. 1164/H.R. 1397-Increasing Access to Dental Insurance Act
Increasing Access to Dental Insurance Act
Client: NATIONAL ASSOCIATION OF DENTAL PLANS · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
S. 1164/H.R. 1397-Increasing Access to Dental Insurance Act
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
BRAINFUTURES via HOOPER, LUNDY & BOOKMAN, P.C.
2026 · third_quarter · Q3
H.R.2623 - Innovative Therapies Centers of Excellence Act of 2025, S. 4220 - Veterans Health Administration Novel Therapeutics Preparedness Act.
Issues related to a pathway for FDA approval of psychedelic drugs and therapies; issues related to reducing barriers to research and increasing federal funding of clinical research trials for psychedelic drugs and therapies; issues related to medical adoption of and access to psychedelic drugs and therapies, including reimbursement and workforce; Public Law No: 119-26, related to implementation of research provisions.
Source: Senate LDA
| GOVERNMENT COUNSEL, LLC (OBO) LUPIN PHARMACEUTICALS, INC. |
| 8 |
| 2019–2020 |
| BROWN RUDNICK, LLP, ON BEHALF OF PRIME THERAPEUTICS | 6 | 2018–2019 |
| BROWN RUDNICK, LLP, ON BEHALF OF LUPIN PHARMACEUTICALS, INC. | 4 | 2018 |
| BROWN RUDNICK, LLP, ON BEHALF OF AMNEAL PHRAMACEUTICALS | 1 | 2018 |
| CONSUMER HEALTH ALLIANCE | 1 | 2026 |
| NONPROFIT KIDNEY CARE ALLIANCE | 1 | 2026 |
Increasing Access to Dental Insurance Act
Client: NATIONAL ASSOCIATION OF DENTAL PLANS · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
S. 1164/H.R. 1397-Increasing Access to Dental Insurance Act
Due Process Continuity of Care Act
Client: ASSOCIATION FOR BEHAVIORAL HEALTHCARE · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
S.3402 - Ensuring Excellence in Mental Health Act; H.R. 1510/S. 1720 - The Due Process Continuity of Care Act; H.R. 2741/S. 1329 - The Providing Empathetic and Effective Recovery (PEER) Support Act, H.R. 2586 -Reentry Act of 2025.
Due Process Continuity of Care Act
Client: ASSOCIATION FOR BEHAVIORAL HEALTHCARE · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 8487/S.3402 - Ensuring Excellence in Mental Health Act; H.R. 1510/S. 1720 - The Due Process Continuity of Care Act; H.R. 2741/S. 1329 - The Providing Empathetic and Effective Recovery (PEER) Support Act, H.R. 2586 -Reentry Act of 2025; H.R. 8081/S. 4202 - Mental Health Access and Provider Supports Act.
Due Process Continuity of Care Act
Client: ASSOCIATION FOR BEHAVIORAL HEALTHCARE · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 8487/S.3402 - Ensuring Excellence in Mental Health Act; H.R. 1510/S. 1720 - The Due Process Continuity of Care Act; H.R. 2741/S. 1329 - The Providing Empathetic and Effective Recovery (PEER) Support Act, H.R. 2586 -Reentry Act of 2025; H.R. 8081/S. 4202 - Mental Health Access and Provider Supports Act.
DOC Access Act of 2025
Client: NATIONAL ASSOCIATION OF DENTAL PLANS · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 1521 - DOC Access Act of 2025; H.R. 7931 - the IDA Act of 2026
DOC Access Act of 2025
Client: NATIONAL ASSOCIATION OF DENTAL PLANS · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 1521 - DOC Access Act of 2025; H.R. 7931 - the IDA Act of 2026
DOC Access Act of 2025
Client: NATIONAL ASSOCIATION OF DENTAL PLANS · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 1521 - DOC Access Act of 2025; H.R. 7931 - the IDA Act of 2026
Reentry Act of 2025
Client: ASSOCIATION FOR BEHAVIORAL HEALTHCARE · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 8487/S.3402 - Ensuring Excellence in Mental Health Act; H.R. 1510/S. 1720 - The Due Process Continuity of Care Act; H.R. 2741/S. 1329 - The Providing Empathetic and Effective Recovery (PEER) Support Act, H.R. 2586 -Reentry Act of 2025; H.R. 8081/S. 4202 - Mental Health Access and Provider Supports Act.
Reentry Act of 2025
Client: ASSOCIATION FOR BEHAVIORAL HEALTHCARE · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
S.3402 - Ensuring Excellence in Mental Health Act; H.R. 1510/S. 1720 - The Due Process Continuity of Care Act; H.R. 2741/S. 1329 - The Providing Empathetic and Effective Recovery (PEER) Support Act, H.R. 2586 -Reentry Act of 2025.
Reentry Act of 2025
Client: ASSOCIATION FOR BEHAVIORAL HEALTHCARE · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 8487/S.3402 - Ensuring Excellence in Mental Health Act; H.R. 1510/S. 1720 - The Due Process Continuity of Care Act; H.R. 2741/S. 1329 - The Providing Empathetic and Effective Recovery (PEER) Support Act, H.R. 2586 -Reentry Act of 2025; H.R. 8081/S. 4202 - Mental Health Access and Provider Supports Act.
Innovative Therapies Centers of Excellence Act of 2025
Client: BRAINFUTURES · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R.2623 - Innovative Therapies Centers of Excellence Act of 2025, S. 4220 - Veterans Health Administration Novel Therapeutics Preparedness Act.
Innovative Therapies Centers of Excellence Act of 2025
Client: BRAINFUTURES · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R.2623 - Innovative Therapies Centers of Excellence Act of 2025, S. 4220 - Veterans Health Administration Novel Therapeutics Preparedness Act.
Innovative Therapies Centers of Excellence Act of 2025
Client: BRAINFUTURES · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R.2623 - Innovative Therapies Centers of Excellence Act of 2025, S. 4220 - Veterans Health Administration Novel Therapeutics Preparedness Act.
PEER Support Act
Client: ASSOCIATION FOR BEHAVIORAL HEALTHCARE · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 8487/S.3402 - Ensuring Excellence in Mental Health Act; H.R. 1510/S. 1720 - The Due Process Continuity of Care Act; H.R. 2741/S. 1329 - The Providing Empathetic and Effective Recovery (PEER) Support Act, H.R. 2586 -Reentry Act of 2025; H.R. 8081/S. 4202 - Mental Health Access and Provider Supports Act.
PEER Support Act
Client: ASSOCIATION FOR BEHAVIORAL HEALTHCARE · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 8487/S.3402 - Ensuring Excellence in Mental Health Act; H.R. 1510/S. 1720 - The Due Process Continuity of Care Act; H.R. 2741/S. 1329 - The Providing Empathetic and Effective Recovery (PEER) Support Act, H.R. 2586 -Reentry Act of 2025; H.R. 8081/S. 4202 - Mental Health Access and Provider Supports Act.
PEER Support Act
Client: ASSOCIATION FOR BEHAVIORAL HEALTHCARE · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
S.3402 - Ensuring Excellence in Mental Health Act; H.R. 1510/S. 1720 - The Due Process Continuity of Care Act; H.R. 2741/S. 1329 - The Providing Empathetic and Effective Recovery (PEER) Support Act, H.R. 2586 -Reentry Act of 2025.
To amend the Family and Medical Leave Act of 1993 and title 5, United States Code, to clarify that organ donation surgery qualifies as a serious health condition.
Client: NONPROFIT KIDNEY CARE ALLIANCE · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
Living Donor Protection Act (S. 1552 / H.R. 4582 / H.R. 4583).
Living Donor Protection Act of 2025
Client: NONPROFIT KIDNEY CARE ALLIANCE · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
Living Donor Protection Act (S. 1552 / H.R. 4582 / H.R. 4583).
Consolidated Appropriations Act, 2026
Client: BRAINFUTURES · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 7148/Public Law No: 119-75, psychedelic therapies for treatment of mental health and substance use disorders related to the FY26 budget for the Department of Health and Human Services; FY2027 budget related to psychedelic therapies for treatment of mental health and substance use disorders.
IDA Act of 2026
Client: NATIONAL ASSOCIATION OF DENTAL PLANS · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 1521 - DOC Access Act of 2025; H.R. 7931 - the IDA Act of 2026
IDA Act of 2026
Client: NATIONAL ASSOCIATION OF DENTAL PLANS · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 1521 - DOC Access Act of 2025; H.R. 7931 - the IDA Act of 2026
IDA Act of 2026
Client: NATIONAL ASSOCIATION OF DENTAL PLANS · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 1521 - DOC Access Act of 2025; H.R. 7931 - the IDA Act of 2026
Mental Health Access and Provider Support Act of 2026
Client: ASSOCIATION FOR BEHAVIORAL HEALTHCARE · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 8487/S.3402 - Ensuring Excellence in Mental Health Act; H.R. 1510/S. 1720 - The Due Process Continuity of Care Act; H.R. 2741/S. 1329 - The Providing Empathetic and Effective Recovery (PEER) Support Act, H.R. 2586 -Reentry Act of 2025; H.R. 8081/S. 4202 - Mental Health Access and Provider Supports Act.
Mental Health Access and Provider Support Act of 2026
Client: ASSOCIATION FOR BEHAVIORAL HEALTHCARE · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 8487/S.3402 - Ensuring Excellence in Mental Health Act; H.R. 1510/S. 1720 - The Due Process Continuity of Care Act; H.R. 2741/S. 1329 - The Providing Empathetic and Effective Recovery (PEER) Support Act, H.R. 2586 -Reentry Act of 2025; H.R. 8081/S. 4202 - Mental Health Access and Provider Supports Act.
Ensuring Access to Lower-Cost Medicines for Seniors Act of 2026.
Client: GOVERNMENT COUNSEL, LLC (OBO) PRIME THERAPEUTICS · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 8143 Ensuring Access to Lower Cost Medicines for Seniors Act of 2026; Public Law 119-75 - The Consolidated Appropriations Act, provisions regulating pharmacy benefit manager practices.
Concurrent Care for Comfort Act
Client: NONPROFIT KIDNEY CARE ALLIANCE · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
Issues relating to Medicare reimbursement including, Medicare concurrent hospice and dialysis, cuts to Medicaid, policies related to home dialysis and Medicare Advantage; Concurrent Care for Comfort Act (H.R. 8376); Improving Home Dialysis Act (H.R. 8875).
Ensuring Excellence in Mental Health Act
Client: ASSOCIATION FOR BEHAVIORAL HEALTHCARE · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 8487/S.3402 - Ensuring Excellence in Mental Health Act; H.R. 1510/S. 1720 - The Due Process Continuity of Care Act; H.R. 2741/S. 1329 - The Providing Empathetic and Effective Recovery (PEER) Support Act, H.R. 2586 -Reentry Act of 2025; H.R. 8081/S. 4202 - Mental Health Access and Provider Supports Act.
Ensuring Excellence in Mental Health Act
Client: ASSOCIATION FOR BEHAVIORAL HEALTHCARE · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 8487/S.3402 - Ensuring Excellence in Mental Health Act; H.R. 1510/S. 1720 - The Due Process Continuity of Care Act; H.R. 2741/S. 1329 - The Providing Empathetic and Effective Recovery (PEER) Support Act, H.R. 2586 -Reentry Act of 2025; H.R. 8081/S. 4202 - Mental Health Access and Provider Supports Act.
Improving Home Dialysis Act of 2026
Client: NONPROFIT KIDNEY CARE ALLIANCE · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
Issues relating to Medicare reimbursement including, Medicare concurrent hospice and dialysis, cuts to Medicaid, policies related to home dialysis and Medicare Advantage; Concurrent Care for Comfort Act (H.R. 8376); Improving Home Dialysis Act (H.R. 8875).
Increasing Access to Dental Insurance Act
Client: NATIONAL ASSOCIATION OF DENTAL PLANS · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
S. 1164/H.R. 1397-Increasing Access to Dental Insurance Act
Increasing Access to Dental Insurance Act
Client: NATIONAL ASSOCIATION OF DENTAL PLANS · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
S. 1164/H.R. 1397-Increasing Access to Dental Insurance Act
Increasing Access to Dental Insurance Act
Client: NATIONAL ASSOCIATION OF DENTAL PLANS · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
S. 1164/H.R. 1397-Increasing Access to Dental Insurance Act
PEER Support Act
Client: ASSOCIATION FOR BEHAVIORAL HEALTHCARE · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 8487/S.3402 - Ensuring Excellence in Mental Health Act; H.R. 1510/S. 1720 - The Due Process Continuity of Care Act; H.R. 2741/S. 1329 - The Providing Empathetic and Effective Recovery (PEER) Support Act, H.R. 2586 -Reentry Act of 2025; H.R. 8081/S. 4202 - Mental Health Access and Provider Supports Act.
PEER Support Act
Client: ASSOCIATION FOR BEHAVIORAL HEALTHCARE · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 8487/S.3402 - Ensuring Excellence in Mental Health Act; H.R. 1510/S. 1720 - The Due Process Continuity of Care Act; H.R. 2741/S. 1329 - The Providing Empathetic and Effective Recovery (PEER) Support Act, H.R. 2586 -Reentry Act of 2025; H.R. 8081/S. 4202 - Mental Health Access and Provider Supports Act.
PEER Support Act
Client: ASSOCIATION FOR BEHAVIORAL HEALTHCARE · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
S.3402 - Ensuring Excellence in Mental Health Act; H.R. 1510/S. 1720 - The Due Process Continuity of Care Act; H.R. 2741/S. 1329 - The Providing Empathetic and Effective Recovery (PEER) Support Act, H.R. 2586 -Reentry Act of 2025.
Living Donor Protection Act of 2025
Client: NONPROFIT KIDNEY CARE ALLIANCE · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
Living Donor Protection Act (S. 1552 / H.R. 4582 / H.R. 4583).
Due Process Continuity of Care Act
Client: ASSOCIATION FOR BEHAVIORAL HEALTHCARE · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
S.3402 - Ensuring Excellence in Mental Health Act; H.R. 1510/S. 1720 - The Due Process Continuity of Care Act; H.R. 2741/S. 1329 - The Providing Empathetic and Effective Recovery (PEER) Support Act, H.R. 2586 -Reentry Act of 2025.
Due Process Continuity of Care Act
Client: ASSOCIATION FOR BEHAVIORAL HEALTHCARE · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 8487/S.3402 - Ensuring Excellence in Mental Health Act; H.R. 1510/S. 1720 - The Due Process Continuity of Care Act; H.R. 2741/S. 1329 - The Providing Empathetic and Effective Recovery (PEER) Support Act, H.R. 2586 -Reentry Act of 2025; H.R. 8081/S. 4202 - Mental Health Access and Provider Supports Act.
Due Process Continuity of Care Act
Client: ASSOCIATION FOR BEHAVIORAL HEALTHCARE · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 8487/S.3402 - Ensuring Excellence in Mental Health Act; H.R. 1510/S. 1720 - The Due Process Continuity of Care Act; H.R. 2741/S. 1329 - The Providing Empathetic and Effective Recovery (PEER) Support Act, H.R. 2586 -Reentry Act of 2025; H.R. 8081/S. 4202 - Mental Health Access and Provider Supports Act.
Patients Deserve Price Tags Act
Client: GOVERNMENT COUNSEL, LLC (OBO) PRIME THERAPEUTICS · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
HCR: S. 2355 Patients Deserve Price Tags Act provisions related to drug price transparency and patient transparency tools; Department of Labors Notice of Proposed Rulemaking, Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure (RIN 1210-AB37).
Patients Deserve Price Tags Act
Client: GOVERNMENT COUNSEL, LLC (OBO) PRIME THERAPEUTICS · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
S. 2355 Patients Deserve Price Tags Act provisions related to drug price transparency and patient transparency tools; Department of Labors Notice of Proposed Rulemaking, Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure (RIN 1210-AB37).
Ensuring Excellence in Mental Health Act
Client: ASSOCIATION FOR BEHAVIORAL HEALTHCARE · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 8487/S.3402 - Ensuring Excellence in Mental Health Act; H.R. 1510/S. 1720 - The Due Process Continuity of Care Act; H.R. 2741/S. 1329 - The Providing Empathetic and Effective Recovery (PEER) Support Act, H.R. 2586 -Reentry Act of 2025; H.R. 8081/S. 4202 - Mental Health Access and Provider Supports Act.
Ensuring Excellence in Mental Health Act
Client: ASSOCIATION FOR BEHAVIORAL HEALTHCARE · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
S.3402 - Ensuring Excellence in Mental Health Act; H.R. 1510/S. 1720 - The Due Process Continuity of Care Act; H.R. 2741/S. 1329 - The Providing Empathetic and Effective Recovery (PEER) Support Act, H.R. 2586 -Reentry Act of 2025.
Ensuring Excellence in Mental Health Act
Client: ASSOCIATION FOR BEHAVIORAL HEALTHCARE · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 8487/S.3402 - Ensuring Excellence in Mental Health Act; H.R. 1510/S. 1720 - The Due Process Continuity of Care Act; H.R. 2741/S. 1329 - The Providing Empathetic and Effective Recovery (PEER) Support Act, H.R. 2586 -Reentry Act of 2025; H.R. 8081/S. 4202 - Mental Health Access and Provider Supports Act.
Mental Health Access and Provider Support Act of 2026
Client: ASSOCIATION FOR BEHAVIORAL HEALTHCARE · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 8487/S.3402 - Ensuring Excellence in Mental Health Act; H.R. 1510/S. 1720 - The Due Process Continuity of Care Act; H.R. 2741/S. 1329 - The Providing Empathetic and Effective Recovery (PEER) Support Act, H.R. 2586 -Reentry Act of 2025; H.R. 8081/S. 4202 - Mental Health Access and Provider Supports Act.
Mental Health Access and Provider Support Act of 2026
Client: ASSOCIATION FOR BEHAVIORAL HEALTHCARE · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 8487/S.3402 - Ensuring Excellence in Mental Health Act; H.R. 1510/S. 1720 - The Due Process Continuity of Care Act; H.R. 2741/S. 1329 - The Providing Empathetic and Effective Recovery (PEER) Support Act, H.R. 2586 -Reentry Act of 2025; H.R. 8081/S. 4202 - Mental Health Access and Provider Supports Act.
Veterans Health Administration Novel Therapeutics Preparedness Act
Client: BRAINFUTURES · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R.2623 - Innovative Therapies Centers of Excellence Act of 2025, S. 4220 - Veterans Health Administration Novel Therapeutics Preparedness Act.
Veterans Health Administration Novel Therapeutics Preparedness Act
Client: BRAINFUTURES · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R.2623 - Innovative Therapies Centers of Excellence Act of 2025, S. 4220 - Veterans Health Administration Novel Therapeutics Preparedness Act.
Veterans Health Administration Novel Therapeutics Preparedness Act
Client: BRAINFUTURES · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R.2623 - Innovative Therapies Centers of Excellence Act of 2025, S. 4220 - Veterans Health Administration Novel Therapeutics Preparedness Act.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: ASSOCIATION FOR BEHAVIORAL HEALTHCARE · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
Issues related to behavioral health care, H.R. 1 - The One Big Beautiful Bill Act, provisions related to Medicaid, mental health and substance use services; H.R. 2586 -Reentry Act of 2025; Pending reintroduction of the Ensuring Excellence in Mental Health Act, H.R. 1510/S. 1720 - The Due Process Continuity of Care Act, H.R. 2741/S. 1329 - The Providing Empathetic and Effective Recovery (PEER) Support Act.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NATIONAL ASSOCIATION OF DENTAL PLANS · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 1 - The One Big Beautiful Bill Act, issues related to access to Medicaid dental benefits.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: ASSOCIATION FOR BEHAVIORAL HEALTHCARE · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
Issues related to behavioral health care, H.R. 1 - The One Big Beautiful Bill Act, provisions related to Medicaid, mental health and substance use services; H.R. 2586 -Reentry Act of 2025
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: ASSOCIATION FOR BEHAVIORAL HEALTHCARE · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
Issues related to behavioral health care, H.R. 1 - The One Big Beautiful Bill Act, provisions related to Medicaid, mental health and substance use services; H.R. 2586 - Reentry Act of 2025; H.R. 2741/S. 1329 - The Providing Empathetic and Effective Recovery (PEER) Support Act; S. 3402 - Ensuring Excellence in Mental Health Act.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NATIONAL ASSOCIATION OF DENTAL PLANS · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 1 - The One Big Beautiful Bill Act, issues related to access to Medicaid dental benefits.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: GOVERNMENT COUNSEL, LLC (OBO) PRIME THERAPEUTICS · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 2214 - DRUG Act; H.R. 1 - The One Big Beautiful Bill Act
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NATIONAL ASSOCIATION OF DENTAL PLANS · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 1 - The One Big Beautiful Bill Act, issues related to access to Medicaid dental benefits.
Increasing Access to Dental Insurance Act
Client: NATIONAL ASSOCIATION OF DENTAL PLANS · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
S. 1164/H.R. 1397-Increasing Access to Dental Insurance Act
Increasing Access to Dental Insurance Act
Client: NATIONAL ASSOCIATION OF DENTAL PLANS · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
S. 1164/H.R. 1397-Increasing Access to Dental Insurance Act
Increasing Access to Dental Insurance Act
Client: NATIONAL ASSOCIATION OF DENTAL PLANS · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
S. 1164/H.R. 1397-Increasing Access to Dental Insurance Act
Increasing Access to Dental Insurance Act
Client: NATIONAL ASSOCIATION OF DENTAL PLANS · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
S. 1164/H.R. 1397-Increasing Access to Dental Insurance Act
Due Process Continuity of Care Act
Client: ASSOCIATION FOR BEHAVIORAL HEALTHCARE · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
Issues related to behavioral health care, H.R. 1 - The One Big Beautiful Bill Act, provisions related to Medicaid, mental health and substance use services; H.R. 2586 -Reentry Act of 2025; Pending reintroduction of the Ensuring Excellence in Mental Health Act, H.R. 1510/S. 1720 - The Due Process Continuity of Care Act, H.R. 2741/S. 1329 - The Providing Empathetic and Effective Recovery (PEER) Support Act.
DOC Access Act of 2025
Client: NATIONAL ASSOCIATION OF DENTAL PLANS · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 1521 - DOC Access Act of 2025
DOC Access Act of 2025
Client: NATIONAL ASSOCIATION OF DENTAL PLANS · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 1521 - DOC Access Act of 2025
DOC Access Act of 2025
Client: NATIONAL ASSOCIATION OF DENTAL PLANS · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 1521 - DOC Access Act of 2025
DOC Access Act of 2025
Client: NATIONAL ASSOCIATION OF DENTAL PLANS · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 1521 - DOC Access Act of 2025
DRUG Act
Client: GOVERNMENT COUNSEL, LLC (OBO) PRIME THERAPEUTICS · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 2214 - DRUG Act
DRUG Act
Client: GOVERNMENT COUNSEL, LLC (OBO) PRIME THERAPEUTICS · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 2214 - DRUG Act
DRUG Act
Client: GOVERNMENT COUNSEL, LLC (OBO) PRIME THERAPEUTICS · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 2214 - DRUG Act
DRUG Act
Client: GOVERNMENT COUNSEL, LLC (OBO) PRIME THERAPEUTICS · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 2214 - DRUG Act; H.R. 1 - The One Big Beautiful Bill Act
Reentry Act of 2025
Client: ASSOCIATION FOR BEHAVIORAL HEALTHCARE · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
Issues related to behavioral health care, H.R. 2586 - The Reentry Act.
Reentry Act of 2025
Client: ASSOCIATION FOR BEHAVIORAL HEALTHCARE · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
Issues related to behavioral health care, H.R. 1 - The One Big Beautiful Bill Act, provisions related to Medicaid, mental health and substance use services; H.R. 2586 -Reentry Act of 2025
Reentry Act of 2025
Client: ASSOCIATION FOR BEHAVIORAL HEALTHCARE · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
Issues related to behavioral health care, H.R. 1 - The One Big Beautiful Bill Act, provisions related to Medicaid, mental health and substance use services; H.R. 2586 - Reentry Act of 2025; H.R. 2741/S. 1329 - The Providing Empathetic and Effective Recovery (PEER) Support Act; S. 3402 - Ensuring Excellence in Mental Health Act.
Reentry Act of 2025
Client: ASSOCIATION FOR BEHAVIORAL HEALTHCARE · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
Issues related to behavioral health care, H.R. 1 - The One Big Beautiful Bill Act, provisions related to Medicaid, mental health and substance use services; H.R. 2586 -Reentry Act of 2025; Pending reintroduction of the Ensuring Excellence in Mental Health Act, H.R. 1510/S. 1720 - The Due Process Continuity of Care Act, H.R. 2741/S. 1329 - The Providing Empathetic and Effective Recovery (PEER) Support Act.
Innovative Therapies Centers of Excellence Act of 2025
Client: BRAINFUTURES · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 3944 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026, funding and report language related to psychedelic research, H.R.2623 - Innovative Therapies Centers of Excellence Act of 2025.
Innovative Therapies Centers of Excellence Act of 2025
Client: BRAINFUTURES · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 3944 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026, funding and report language related to psychedelic research, H.R.2623 - Innovative Therapies Centers of Excellence Act of 2025.
PEER Support Act
Client: ASSOCIATION FOR BEHAVIORAL HEALTHCARE · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
Issues related to behavioral health care, H.R. 1 - The One Big Beautiful Bill Act, provisions related to Medicaid, mental health and substance use services; H.R. 2586 - Reentry Act of 2025; H.R. 2741/S. 1329 - The Providing Empathetic and Effective Recovery (PEER) Support Act; S. 3402 - Ensuring Excellence in Mental Health Act.
PEER Support Act
Client: ASSOCIATION FOR BEHAVIORAL HEALTHCARE · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
Issues related to behavioral health care, H.R. 1 - The One Big Beautiful Bill Act, provisions related to Medicaid, mental health and substance use services; H.R. 2586 -Reentry Act of 2025; Pending reintroduction of the Ensuring Excellence in Mental Health Act, H.R. 1510/S. 1720 - The Due Process Continuity of Care Act, H.R. 2741/S. 1329 - The Providing Empathetic and Effective Recovery (PEER) Support Act.
Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026
Client: BRAINFUTURES · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 3944 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026, funding and report language related to psychedelic research, H.R. 5304/S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026, support for psychedelic therapies for treatment of mental health and substance use disorders.
Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026
Client: BRAINFUTURES · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
Issues related to a pathway for FDA approval of psychedelic drugs and therapies; Issues related to reducing barriers to research and increasing federal funding of clinical research trials for psychedelic drugs and therapies; Issues related to medical adoption of and access to psychedelic drugs and therapies, including reimbursement and workforce; S. 331 - HALT Fentanyl Act, provisions related to research.; H.R. 3944 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026, funding and report language related to psychedelic research.
Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026
Client: BRAINFUTURES · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 3944 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026, funding and report language related to psychedelic research, H.R.2623 - Innovative Therapies Centers of Excellence Act of 2025.
Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026
Client: BRAINFUTURES · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 3944 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026, funding and report language related to psychedelic research.
Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026
Client: BRAINFUTURES · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 3944 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026, funding and report language related to psychedelic research, H.R.2623 - Innovative Therapies Centers of Excellence Act of 2025.
Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026
Client: BRAINFUTURES · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 3944 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026, funding and report language related to psychedelic research
Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026
Client: BRAINFUTURES · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
Issues related to a pathway for FDA approval of psychedelic drugs and therapies, issues related to reducing barriers to research and increasing federal funding of clinical research trials for psychedelic drugs and therapies; Issues related to medical adoption of and access to psychedelic drugs and therapies; S. 331 - HALT Fentanyl Act, provisions related to research.; H.R. 3944 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026, funding and report language related to psychedelic research.
Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026
Client: BRAINFUTURES · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
Issues related to a pathway for FDA approval of psychedelic drugs and therapies, issues related to reducing barriers to research and increasing federal funding of clinical research trials for psychedelic drugs and therapies; Issues related to medical adoption of and access to psychedelic drugs and therapies; S. 331 - HALT Fentanyl Act, provisions related to research.; H.R. 3944 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026, funding and report language related to psychedelic research.
Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026
Client: BRAINFUTURES · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 3944 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026, funding and report language related to psychedelic research, H.R. 5304/S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026, support for psychedelic therapies for treatment of mental health and substance use disorders.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: BRAINFUTURES · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 3944 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026, funding and report language related to psychedelic research, H.R. 5304/S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026, support for psychedelic therapies for treatment of mental health and substance use disorders.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: ASSOCIATION FOR BEHAVIORAL HEALTHCARE · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 5304/S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026, support for mental health and substance use programs.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: BRAINFUTURES · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 3944 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026, funding and report language related to psychedelic research, H.R. 5304/S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026, support for psychedelic therapies for treatment of mental health and substance use disorders.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: ASSOCIATION FOR BEHAVIORAL HEALTHCARE · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 5304/S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026, support for mental health and substance use programs.
Increasing Access to Dental Insurance Act
Client: NATIONAL ASSOCIATION OF DENTAL PLANS · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
S. 1164/H.R. 1397-Increasing Access to Dental Insurance Act
Increasing Access to Dental Insurance Act
Client: NATIONAL ASSOCIATION OF DENTAL PLANS · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
S. 1164/H.R. 1397-Increasing Access to Dental Insurance Act
Increasing Access to Dental Insurance Act
Client: NATIONAL ASSOCIATION OF DENTAL PLANS · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
S. 1164/H.R. 1397-Increasing Access to Dental Insurance Act
Increasing Access to Dental Insurance Act
Client: NATIONAL ASSOCIATION OF DENTAL PLANS · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
S. 1164/H.R. 1397-Increasing Access to Dental Insurance Act
PEER Support Act
Client: ASSOCIATION FOR BEHAVIORAL HEALTHCARE · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
Issues related to behavioral health care, H.R. 1 - The One Big Beautiful Bill Act, provisions related to Medicaid, mental health and substance use services; H.R. 2586 - Reentry Act of 2025; H.R. 2741/S. 1329 - The Providing Empathetic and Effective Recovery (PEER) Support Act; S. 3402 - Ensuring Excellence in Mental Health Act.
PEER Support Act
Client: ASSOCIATION FOR BEHAVIORAL HEALTHCARE · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
Issues related to behavioral health care, H.R. 1 - The One Big Beautiful Bill Act, provisions related to Medicaid, mental health and substance use services; H.R. 2586 -Reentry Act of 2025; Pending reintroduction of the Ensuring Excellence in Mental Health Act, H.R. 1510/S. 1720 - The Due Process Continuity of Care Act, H.R. 2741/S. 1329 - The Providing Empathetic and Effective Recovery (PEER) Support Act.
Due Process Continuity of Care Act
Client: ASSOCIATION FOR BEHAVIORAL HEALTHCARE · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
Issues related to behavioral health care, H.R. 1 - The One Big Beautiful Bill Act, provisions related to Medicaid, mental health and substance use services; H.R. 2586 -Reentry Act of 2025; Pending reintroduction of the Ensuring Excellence in Mental Health Act, H.R. 1510/S. 1720 - The Due Process Continuity of Care Act, H.R. 2741/S. 1329 - The Providing Empathetic and Effective Recovery (PEER) Support Act.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: BRAINFUTURES · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 3944 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026, funding and report language related to psychedelic research, H.R. 5304/S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026, support for psychedelic therapies for treatment of mental health and substance use disorders.
Issues related to a pathway for FDA approval of psychedelic drugs and therapies; issues related to reducing barriers to research and increasing federal funding of clinical research trials for psychedelic drugs and therapies; issues related to medical adoption of and access to psychedelic drugs and therapies, including reimbursement and workforce; Public Law No: 119-26, related to implementation of research provisions.
FY2027 budget related to psychedelic therapies for treatment of mental health and substance use disorders.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF DENTAL PLANS via HOOPER, LUNDY & BOOKMAN, P.C.
2026 · third_quarter · Q3
S. 1164/H.R. 1397-Increasing Access to Dental Insurance Act
Issues related to access to Medicaid dental benefits.
H.R. 1521 - DOC Access Act of 2025; H.R. 7931 - the IDA Act of 2026
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR BEHAVIORAL HEALTHCARE via HOOPER, LUNDY & BOOKMAN, P.C.
2026 · third_quarter · Q3
Issues related to behavioral health care.
H.R. 8487/S.3402 - Ensuring Excellence in Mental Health Act; H.R. 1510/S. 1720 - The Due Process Continuity of Care Act; H.R. 2741/S. 1329 - The Providing Empathetic and Effective Recovery (PEER) Support Act, H.R. 2586 -Reentry Act of 2025; H.R. 8081/S. 4202 - Mental Health Access and Provider Supports Act.
Support for mental health and substance use programs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NONPROFIT KIDNEY CARE ALLIANCE via HOOPER, LUNDY & BOOKMAN, P.C.
2026 · third_quarter · Q3
Issues relating to Medicare reimbursement including, Medicare concurrent hospice and dialysis, cuts to Medicaid, policies related to home dialysis and Medicare Advantage; Concurrent Care for Comfort Act (H.R. 8376); Improving Home Dialysis Act (H.R. 8875).
Living Donor Protection Act (S. 1552 / H.R. 4582 / H.R. 4583).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CONSUMER HEALTH ALLIANCE via HOOPER, LUNDY & BOOKMAN, P.C.
2026 · third_quarter · RR
Education and advocacy related to discount dental plans.
BRAINFUTURES via HOOPER, LUNDY & BOOKMAN, P.C.
2026 · second_quarter · Q2
FY2027 budget related to psychedelic therapies for treatment of mental health and substance use disorders.
H.R.2623 - Innovative Therapies Centers of Excellence Act of 2025, S. 4220 - Veterans Health Administration Novel Therapeutics Preparedness Act.
Issues related to a pathway for FDA approval of psychedelic drugs and therapies; issues related to reducing barriers to research and increasing federal funding of clinical research trials for psychedelic drugs and therapies; issues related to medical adoption of and access to psychedelic drugs and therapies, including reimbursement and workforce; Public Law No: 119-26, related to implementation of research provisions.
Issues related to a pathway for FDA approval of psychedelic drugs and therapies; issues related to reducing barriers to research and increasing federal funding of clinical research trials for psychedelic drugs and therapies; issues related to medical adoption of and access to psychedelic drugs and therapies, including reimbursement and workforce; Public Law No: 119-26, related to implementation of research provisions.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GOVERNMENT COUNSEL, LLC (OBO) PRIME THERAPEUTICS via HOOPER, LUNDY & BOOKMAN, P.C.
2026 · second_quarter · Q2
HCR: S. 2355 Patients Deserve Price Tags Act provisions related to drug price transparency and patient transparency tools; Department of Labors Notice of Proposed Rulemaking, Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure (RIN 1210-AB37).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF DENTAL PLANS via HOOPER, LUNDY & BOOKMAN, P.C.
2026 · second_quarter · Q2
S. 1164/H.R. 1397-Increasing Access to Dental Insurance Act
H.R. 1521 - DOC Access Act of 2025; H.R. 7931 - the IDA Act of 2026
Issues related to access to Medicaid dental benefits.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR BEHAVIORAL HEALTHCARE via HOOPER, LUNDY & BOOKMAN, P.C.
2026 · second_quarter · Q2
Support for mental health and substance use programs.
Issues related to behavioral health care.
H.R. 8487/S.3402 - Ensuring Excellence in Mental Health Act; H.R. 1510/S. 1720 - The Due Process Continuity of Care Act; H.R. 2741/S. 1329 - The Providing Empathetic and Effective Recovery (PEER) Support Act, H.R. 2586 -Reentry Act of 2025; H.R. 8081/S. 4202 - Mental Health Access and Provider Supports Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRAINFUTURES via HOOPER, LUNDY & BOOKMAN, P.C.
2026 · first_quarter · Q1
Issues related to a pathway for FDA approval of psychedelic drugs and therapies; issues related to reducing barriers to research and increasing federal funding of clinical research trials for psychedelic drugs and therapies; issues related to medical adoption of and access to psychedelic drugs and therapies, including reimbursement and workforce; Public Law No: 119-26, related to implementation of research provisions.
H.R.2623 - Innovative Therapies Centers of Excellence Act of 2025, S. 4220 - Veterans Health Administration Novel Therapeutics Preparedness Act.
Issues related to a pathway for FDA approval of psychedelic drugs and therapies; issues related to reducing barriers to research and increasing federal funding of clinical research trials for psychedelic drugs and therapies; issues related to medical adoption of and access to psychedelic drugs and therapies, including reimbursement and workforce; Public Law No: 119-26, related to implementation of research provisions.
GOVERNMENT COUNSEL, LLC (OBO) PRIME THERAPEUTICS via HOOPER, LUNDY & BOOKMAN, P.C.
2026 · first_quarter · Q1
S. 2355 Patients Deserve Price Tags Act provisions related to drug price transparency and patient transparency tools; Department of Labors Notice of Proposed Rulemaking, Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure (RIN 1210-AB37).
H.R. 8143 Ensuring Access to Lower Cost Medicines for Seniors Act of 2026; Public Law 119-75 - The Consolidated Appropriations Act, provisions regulating pharmacy benefit manager practices.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF DENTAL PLANS via HOOPER, LUNDY & BOOKMAN, P.C.
2026 · first_quarter · Q1
S. 1164/H.R. 1397-Increasing Access to Dental Insurance Act
H.R. 1521 - DOC Access Act of 2025; H.R. 7931 - the IDA Act of 2026
Issues related to access to Medicaid dental benefits.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR BEHAVIORAL HEALTHCARE via HOOPER, LUNDY & BOOKMAN, P.C.
2026 · first_quarter · Q1
Issues related to behavioral health care.
S.3402 - Ensuring Excellence in Mental Health Act; H.R. 1510/S. 1720 - The Due Process Continuity of Care Act; H.R. 2741/S. 1329 - The Providing Empathetic and Effective Recovery (PEER) Support Act, H.R. 2586 -Reentry Act of 2025.
Support for mental health and substance use programs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRAINFUTURES via HOOPER, LUNDY & BOOKMAN, P.C.
2025 · fourth_quarter · Q4
Issues related to a pathway for FDA approval of psychedelic drugs and therapies; Issues related to reducing barriers to research and increasing federal funding of clinical research trials for psychedelic drugs and therapies; Issues related to medical adoption of and access to psychedelic drugs and therapies, including reimbursement and workforce; S. 331 - HALT Fentanyl Act, provisions related to research.; H.R. 3944 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026, funding and report language related to psychedelic research.
Issues related to a pathway for FDA approval of psychedelic drugs and therapies; Issues related to reducing barriers to research and increasing federal funding of clinical research trials for psychedelic drugs and therapies, including reimbursement and workforce; Issues related to medical adoption of and access to psychedelic drugs and therapies; S. 331 - HALT Fentanyl Act, provisions related to research.
NATIONAL ASSOCIATION OF DENTAL PLANS via HOOPER, LUNDY & BOOKMAN, P.C.
2025 · fourth_quarter · Q4
S. 1164/H.R. 1397-Increasing Access to Dental Insurance Act
H.R. 1521 - DOC Access Act of 2025
H.R. 1 - The One Big Beautiful Bill Act, issues related to access to Medicaid dental benefits.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR BEHAVIORAL HEALTHCARE via HOOPER, LUNDY & BOOKMAN, P.C.
2025 · fourth_quarter · Q4
Issues related to behavioral health care.
Issues related to behavioral health care, H.R. 1 - The One Big Beautiful Bill Act, provisions related to Medicaid, mental health and substance use services; H.R. 2586 - Reentry Act of 2025; H.R. 2741/S. 1329 - The Providing Empathetic and Effective Recovery (PEER) Support Act; S. 3402 - Ensuring Excellence in Mental Health Act.
H.R. 5304/S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026, support for mental health and substance use programs.
GOVERNMENT COUNSEL, LLC (OBO) PRIME THERAPEUTICS via HOOPER, LUNDY & BOOKMAN, P.C.
2025 · fourth_quarter · Q4
S. 891 - The Bipartisan Health Care Act
H.R. 2214 - DRUG Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRAINFUTURES via HOOPER, LUNDY & BOOKMAN, P.C.
2025 · third_quarter · Q3
H.R. 3944 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026, funding and report language related to psychedelic research, H.R.2623 - Innovative Therapies Centers of Excellence Act of 2025.
Issues related to a pathway for FDA approval of psychedelic drugs and therapies, issues related to reducing barriers to research and increasing federal funding of clinical research trials for psychedelic drugs and therapies; Issues related to medical adoption of and access to psychedelic drugs and therapies; S. 331 - HALT Fentanyl Act, provisions related to research.; H.R. 3944 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026, funding and report language related to psychedelic research.
GOVERNMENT COUNSEL, LLC (OBO) PRIME THERAPEUTICS via HOOPER, LUNDY & BOOKMAN, P.C.
2025 · third_quarter · Q3
S. 891 - The Bipartisan Health Care Act
H.R. 2214 - DRUG Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR BEHAVIORAL HEALTHCARE via HOOPER, LUNDY & BOOKMAN, P.C.
2025 · third_quarter · Q3
Issues related to behavioral health care.
Issues related to behavioral health care, H.R. 1 - The One Big Beautiful Bill Act, provisions related to Medicaid, mental health and substance use services; H.R. 2586 -Reentry Act of 2025; Pending reintroduction of the Ensuring Excellence in Mental Health Act, H.R. 1510/S. 1720 - The Due Process Continuity of Care Act, H.R. 2741/S. 1329 - The Providing Empathetic and Effective Recovery (PEER) Support Act.
H.R. 5304/S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026, support for mental health and substance use programs.
NATIONAL ASSOCIATION OF DENTAL PLANS via HOOPER, LUNDY & BOOKMAN, P.C.
2025 · third_quarter · Q3
S. 1164/H.R. 1397-Increasing Access to Dental Insurance Act
H.R. 1521 - DOC Access Act of 2025
H.R. 1 - The One Big Beautiful Bill Act, issues related to access to Medicaid dental benefits.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRAINFUTURES via HOOPER, LUNDY & BOOKMAN, P.C.
2025 · second_quarter · Q2
Issues related to a pathway for FDA approval of psychedelic drugs and therapies, issues related to reducing barriers to research and increasing federal funding of clinical research trials for psychedelic drugs and therapies; Issues related to medical adoption of and access to psychedelic drugs and therapies; S. 331 - HALT Fentanyl Act, provisions related to research.; H.R. 3944 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026, funding and report language related to psychedelic research.
Issues related to a pathway for FDA approval of psychedelic drugs and therapies, issues related to reducing barriers to research and increasing federal funding of clinical research trials for psychedelic drugs and therapies; Issues related to medical adoption of and access to psychedelic drugs and therapies; S. 331 - HALT Fentanyl Act, provisions related to research.
GOVERNMENT COUNSEL, LLC (OBO) PRIME THERAPEUTICS via HOOPER, LUNDY & BOOKMAN, P.C.
2025 · second_quarter · Q2
S. 891 - The Bipartisan Health Care Act
H.R. 2214 - DRUG Act; H.R. 1 - The One Big Beautiful Bill Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF DENTAL PLANS via HOOPER, LUNDY & BOOKMAN, P.C.
2025 · second_quarter · Q2
S. 1164/H.R. 1397-Increasing Access to Dental Insurance Act
H.R. 1521 - DOC Access Act of 2025
H.R. 1 - The One Big Beautiful Bill Act, issues related to access to Medicaid dental benefits.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR BEHAVIORAL HEALTHCARE via HOOPER, LUNDY & BOOKMAN, P.C.
2025 · second_quarter · Q2
Issues related to behavioral health care.
Issues related to behavioral health care, H.R. 1 - The One Big Beautiful Bill Act, provisions related to Medicaid, mental health and substance use services; H.R. 2586 -Reentry Act of 2025
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF DENTAL PLANS via HOOPER, LUNDY & BOOKMAN, P.C.
2025 · first_quarter · Q1
S. 1164/H.R. 1397-Increasing Access to Dental Insurance Act
H.R. 1521 - DOC Access Act of 2025
Issues related to access to Medicaid dental benefits.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRAINFUTURES via HOOPER, LUNDY & BOOKMAN, P.C.
2025 · first_quarter · Q1
Issues related to a pathway for FDA approval of psychedelic drugs and therapies, issues related to reducing barriers to research and increasing federal funding of clinical research trials for psychedelic drugs and therapies; Issues related to medical adoption of and access to psychedelic drugs and therapies; S. 331 - HALT Fentanyl Act, provisions related to research.
Issues related to a pathway for FDA approval of psychedelic drugs and therapies, issues related to reducing barriers to research and increasing federal funding of clinical research trials for psychedelic drugs and therapies; Issues related to medical adoption of and access to psychedelic drugs and therapies; S. 331 - HALT Fentanyl Act, provisions related to research.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GOVERNMENT COUNSEL, LLC (OBO) PRIME THERAPEUTICS via HOOPER, LUNDY & BOOKMAN, P.C.
2025 · first_quarter · Q1
S. 891 - The Bipartisan Health Care Act
H.R. 2214 - DRUG Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR BEHAVIORAL HEALTHCARE via HOOPER, LUNDY & BOOKMAN, P.C.
2025 · first_quarter · Q1
Issues related to behavioral health care.
Issues related to behavioral health care, H.R. 2586 - The Reentry Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRAINFUTURES via HOOPER, LUNDY & BOOKMAN, P.C.
2024 · fourth_quarter · Q4
Issues related to reducing barriers to research and increasing federal funding of clinical research trials for psychedelic drugs and therapies, Issues related to medical adoption of psychedelic drugs and therapies, Issues related to equitable access to psychedelic drugs and therapies, Issues related to a pathway for FDA approval of psychedelic drugs and therapies, S. 689/H.R. 1393, a bill to amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes, all provisions.
Issues related to reducing barriers to research and increasing federal funding of clinical research trials for psychedelic drugs and therapies, Issues related to medical adoption of psychedelic drugs and therapies, Issues related to equitable access to psychedelic drugs and therapies, Issues related to a pathway for FDA approval of psychedelic drugs and therapies, S. 689/H.R. 1393, a bill to amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes, all provisions.
ROCHE DIAGNOSTICS CORPORATION via HOOPER, LUNDY & BOOKMAN, P.C.
2024 · fourth_quarter · 4T
Issues related to clinical diagnostic laboratory services; issues related to public health emergency preparedness; H.R. 3975 - The Diagnostics Testing Preparedness Plan; H.R. 10445 - Further Continuing Appropriation and Disaster Relief Supplemental Appropriations Act of 2025
S.1000 / HR 2377 - Saving Access to Laboratory Services Act (SALSA); H.R. 1691 - Ensuring Patient Access to Critical Breakthrough Products Act of 2023; H.R. 10445 - Further Continuing Appropriation and Disaster Relief Supplemental Appropriations Act of 2025
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GOVERNMENT COUNSEL, LLC (OBO) PRIME THERAPEUTICS via HOOPER, LUNDY & BOOKMAN, P.C.
2024 · fourth_quarter · Q4
H.R. 9096 - Pharmacists Fight Back Act; H.R. 10445, Further Continuing Appropriation and Disaster Relief Supplemental Appropriations Act of 2025
H. R. 10050, Pharmacist Audit & Compensation Transparency Act; S. 2305, The Biosimilar Red Tape Elimination Act; H.R. 10445, Further Continuing Appropriation and Disaster Relief Supplemental Appropriations Act of 2025
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF DENTAL PLANS via HOOPER, LUNDY & BOOKMAN, P.C.
2024 · fourth_quarter · Q4
S. 4942/H.R. 9029 Appropriations for Department of Health and Human Services FY 2025, specifically against measures to increase consumer cost-sharing for oral health services, H.R. 10445 - Further Continuing Appropriation and Disaster Relief Supplemental Appropriations Act of 2025.
H.R. 1671/S. 2771 Increasing Access to Dental Insurance Act; Issues related to operation of the Affordable Care Act exchanges, Issues related to expanding access to dental benefits, H.R. 10445 - Further Continuing Appropriation and Disaster Relief Supplemental Appropriations Act of 2025.
ASSOCIATION FOR BEHAVIORAL HEALTHCARE via HOOPER, LUNDY & BOOKMAN, P.C.
2024 · fourth_quarter · Q4
S.462/H.R. 4933, Mental Health Professionals Workforce Shortage Loan Repayment Act; S.3393/H.R. 4531, SUPPORT for Patients and Communities Act.
S. 2993/H.R. 8543, Ensuring Excellence in Mental Health Act; S. 838/H.R. 1638, Improving Access to Mental Health Act; S. 1165/H.R. 2400, Reentry Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRAINFUTURES via HOOPER, LUNDY & BOOKMAN, P.C.
2024 · third_quarter · Q3
Issues related to a pathway for FDA approval of psychedelic drugs and therapies, issues related to reducing barriers to research and increasing federal funding of clinical research trials for psychedelic drugs and therapies, issues related to medical adoption of psychedelic drugs and therapies, issues related to equitable access to psychedelic drugs and therapies; S. 689/H.R. 1393, A bill to amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes, all provisions.
Issues related to a pathway for FDA approval of psychedelic drugs and therapies, issues related to reducing barriers to research and increasing federal funding of clinical research trials for psychedelic drugs and therapies, issues related to medical adoption of psychedelic drugs and therapies, issues related to equitable access to psychedelic drugs and therapies; S. 689/H.R. 1393, A bill to amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes, all provisions.
GOVERNMENT COUNSEL, LLC (OBO) PRIME THERAPEUTICS via HOOPER, LUNDY & BOOKMAN, P.C.
2024 · third_quarter · Q3
S. 2973-Modernizing and Ensuring PBM Accountability Act; S. 3430 - Better Mental Healthcare, Lower Cost Drugs & Extenders Act (provisions related to PBMs and pharmacy contracting); H.R. 5526 - Seniors Access to Critical Medications Act of 2023; H.R. 7623 - Telehealth Modernization Act of 2024
S. 1339 - Pharmacy Benefit Manager Reform Act; H.R. 5378 -Lower Costs, More Transparency Act; S. 1542/H.R. 6283 -The Delinking Revenue from Unfair Gouging (DRUG) Act; S. 127 - Pharmacy Benefit Manager Transparency Act of 2023.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF DENTAL PLANS via HOOPER, LUNDY & BOOKMAN, P.C.
2024 · third_quarter · Q3
H.R. 1342/S. 570 Medicaid Dental Benefit Act of 2023.
H.R. 1385/S. 1424 DOC Access Act of 2023.
S. 4942/H.R. 9029 Appropriations for Department of Health and Human Services FY 2025, specifically against measures to increase consumer cost-sharing for oral health services.
ROCHE DIAGNOSTICS CORPORATION via HOOPER, LUNDY & BOOKMAN, P.C.
2024 · third_quarter · Q3
Issues related to clinical diagnostic laboratory services; H.R. 2369 The Verifying Leading-edge IVCT Development Act.
S.1000 / HR 2377 Saving Access to Laboratory Services Act (SALSA); H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR BEHAVIORAL HEALTHCARE via HOOPER, LUNDY & BOOKMAN, P.C.
2024 · third_quarter · Q3
S.462/H.R. 4933, Mental Health Professionals Workforce Shortage Loan Repayment Act; S.3393/H.R. 4531, SUPPORT for Patients and Communities Act.
S. 2993/H.R. 8543, Ensuring Excellence in Mental Health Act; S. 838/H.R. 1638, Improving Access to Mental Health Act; S. 1165/H.R. 2400, Reentry Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRAINFUTURES via HOOPER, LUNDY & BOOKMAN, P.C.
2024 · third_quarter · RR
Education and advocacy related to treatments for mental health and substance use disorder.
Education and advocacy related to treatments for mental health and substance use disorder.
GOVERNMENT COUNSEL, LLC (OBO) PRIME THERAPEUTICS via HOOPER, LUNDY & BOOKMAN, P.C.
2024 · second_quarter · Q2
S. 2973-Modernizing and Ensuring PBM Accountability Act; S. 3430 - Better Mental Healthcare, Lower Cost Drugs & Extenders Act (provisions related to PBMs and pharmacy contracting); H.R. 5526 - Seniors Access to Critical Medications Act of 2023; H.R. 7623 - Telehealth Modernization Act of 2024
S. 1339 - Pharmacy Benefit Manager Reform Act; H.R. 5378 -Lower Costs, More Transparency Act; S. 1542/H.R. 6283 -The Delinking Revenue from Unfair Gouging (DRUG) Act; S. 127 - Pharmacy Benefit Manager Transparency Act of 2023.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ROCHE DIAGNOSTICS CORPORATION via HOOPER, LUNDY & BOOKMAN, P.C.
2024 · second_quarter · Q2
S.1000 / HR 2377 Saving Access to Laboratory Services Act (SALSA); H.R. 7623-Telehealth Modernization Act of 2024 regarding phase-in of Medicare clinical laboratory test payment; H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Issues related to clinical diagnostic laboratory services; H.R. 2369 The Verifying Leading-edge IVCT Development Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR BEHAVIORAL HEALTHCARE via HOOPER, LUNDY & BOOKMAN, P.C.
2024 · second_quarter · Q2
S. 2993/H.R. 8543, Ensuring Excellence in Mental Health Act; S. 838/H.R. 1638, Improving Access to Mental Health Act; S. 1165/H.R. 2400, Reentry Act.
S.462/H.R. 4933, Mental Health Professionals Workforce Shortage Loan Repayment Act; S.3393/H.R. 4531, SUPPORT for Patients and Communities Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF DENTAL PLANS via HOOPER, LUNDY & BOOKMAN, P.C.
2024 · second_quarter · Q2
H.R. 1385/S. 1424 DOC Access Act of 2023.
H.R. 1671/S. 2771 Increasing Access to Dental Insurance Act; Issues related to operation of the Affordable Care Act exchanges, Issues related to expanding access to dental benefits.
H.R. 1342/S. 570 Medicaid Dental Benefit Act of 2023.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GOVERNMENT COUNSEL, LLC (OBO) PRIME THERAPEUTICS via HOOPER, LUNDY & BOOKMAN, P.C.
2024 · first_quarter · Q1
HCR: S 1339 - Pharmacy Benefit Manager Reform Act; H.R. 5378 -Lower Costs, More Transparency Act; S. 1542/H.R. 6283 -The Delinking Revenue from Unfair Gouging (DRUG) Act; S. 3548 -A bill to amend the Public Health Services Act to provide for hospital and insurer price transparency; S. 127 - Pharmacy Benefit Manager Transparency Act of 2023.
Issues relating to oversight of PBM services; S. 2973-Modernizing and Ensuring PBM Accountability Act; S. 3430 - Better Mental Healthcare, Lower Cost Drugs & Extenders Act (provisions related to PBMs and pharmacy contracting; H.R. 5526 - Seniors Access to Critical Medications Act of 2023; S. 2305 - Biosimilars Red Tape Elimination Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF DENTAL PLANS via HOOPER, LUNDY & BOOKMAN, P.C.
2024 · first_quarter · Q1
H.R. 1671/S. 2771 Increasing Access to Dental Insurance Act; Issues related to operation of the Affordable Care Act exchanges, Issues related to expanding access to dental benefits.
H.R. 1342/S. 570 Medicaid Dental Benefit Act of 2023.
H.R. 1385/S. 1424 DOC Access Act of 2023.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ROCHE DIAGNOSTICS CORPORATION via HOOPER, LUNDY & BOOKMAN, P.C.
2024 · first_quarter · Q1
S. 1000/H.R. 2377 Saving Access to Laboratory Services (SALSA); H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Issues related to clinical diagnostic laboratory services; H.R. 2369 The Verifying Leading-edge IVCT Development Act, S. 2333 Pandemic and All-Hazards Preparedness and Response Act, issues related to public health emergency preparedness.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR BEHAVIORAL HEALTHCARE via HOOPER, LUNDY & BOOKMAN, P.C.
2024 · first_quarter · Q1
Issues related to behavioral health care; Issues related to workforce shortages; Issues related to substance use; Issues related to telehealth flexibilities; H.R. 4531, SUPPORT for Patients and Communities Reauthorization Act; S. 3393 SUPPORT Act, S. 644 Modernizing Opioid Treatment Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GOVERNMENT COUNSEL, LLC (OBO) PRIME THERAPEUTICS via HOOPER, LUNDY & BOOKMAN, P.C.
2023 · fourth_quarter · Q4
Pharmacy Benefit Manager Reform Act; H.R. 3682 of the 117th Congress - Improving Transparency to Lower Drugs Costs Act of 2021; H.R. 5378 -Lower Costs, More Transparency Act; S. 1542/H.R. 6283 -The Delinking Revenue from Unfair Gouging (DRUG) Act; S. 3548 -A bill to amend the Public Health Services Act to provide for hospital and insurer price transparency; Transparency in Coverage Final Rule (CMS-9915-F) provisions related to machine readable drug files.
Issues relating to oversight of PBM services; S. 2973-Modernizing and Ensuring PBM Accountability Act; S. 3430 - Better Mental Healthcare, Lower Cost Drugs & Extenders Act (provisions related to PBMs and pharmacy contracting); H.R. 2880 - Protecting Patients Against PBM Abuses Act; H.R. 4881 - To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program; S. 2436 -Neighborhood Options for Patients Buying Medicines (NO PBMs) Act; H.R. 5386 - Cutting Copays Act;H.R. 5372 - Expanding Seniors Access to Lower Cost Medicines Act of 2023; H.R. 5393 - The Transparency and Fairness for Pharmacists Act; H.R. 5385 - Medicare PBM Accountability Act
NATIONAL ASSOCIATION OF DENTAL PLANS via HOOPER, LUNDY & BOOKMAN, P.C.
2023 · fourth_quarter · Q4
H.R. 1671/S. 2771 Increasing Access to Dental Insurance Act; Issues related to operation of the Affordable Care Act exchanges, Issues related to expanding access to dental benefits.
H.R. 1385/S. 1424 DOC Access Act of 2023.
H.R. 1342/S. 570 Medicaid Dental Benefit Act of 2023.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ROCHE DIAGNOSTICS CORPORATION via HOOPER, LUNDY & BOOKMAN, P.C.
2023 · fourth_quarter · Q4
S. 1000/H.R. 2377 Saving Access to Laboratory Services (SALSA); H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Issues related to clinical diagnostic laboratory services; S. 2333 Pandemic and All-Hazards Preparedness and Response Act, issues related to public health emergency preparedness; HR 4366-Fiscal Year 2024 Minibus Appropriations relating to laboratory developed tests.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR BEHAVIORAL HEALTHCARE via HOOPER, LUNDY & BOOKMAN, P.C.
2023 · fourth_quarter · Q4
Issues related to behavioral health care; Issues related to workforce shortages; Issues related to substance use; Issues related to telehealth flexibilities; H.R. 4531, SUPPORT for Patients and Communities Reauthorization Act; S. 3393 SUPPORT Act, S. 644 Modernizing Opioid Treatment Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GOVERNMENT COUNSEL, LLC (OBO) PRIME THERAPEUTICS via HOOPER, LUNDY & BOOKMAN, P.C.
2023 · third_quarter · Q3
Issues relating to prescription benefit manager transparency; S.1339-Pharmacy Benefit Manager Reform Act; H.R. 5378-The Lower Costs, More Transparency Act; S. 2305 - Biosimilar Red Tape Elimination Act; S. 127 - PBM Transparency Act of 2023.
Issues relating to oversight of PBM services; S. 2973-Modernizing and Ensuring PBM Accountability Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF DENTAL PLANS via HOOPER, LUNDY & BOOKMAN, P.C.
2023 · third_quarter · Q3
H.R. 1342/S. 570 Medicaid Dental Benefit Act of 2023.
H.R. 1671/S. 2771 Increasing Access to Dental Insurance Act; Issues related to operation of the Affordable Care Act exchanges, Issues related to expanding access to dental benefits.
H.R. 1385/S. 1424 DOC Access Act of 2023.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ROCHE DIAGNOSTICS CORPORATION via HOOPER, LUNDY & BOOKMAN, P.C.
2023 · third_quarter · Q3
Issues related to clinical diagnostic laboratory services; Issues related to public health emergency preparedness.
S. 1000/H.R. 2377 Saving Access to Laboratory Services (SALSA).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR BEHAVIORAL HEALTHCARE via HOOPER, LUNDY & BOOKMAN, P.C.
2023 · third_quarter · Q3
Issues related to behavioral health care; Issues related to workforce shortages; Issues related to substance use; Issues related to telehealth flexibilities; H.R. 4531, SUPPORT for Patients and Communities Reauthorization Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GOVERNMENT COUNSEL, LLC (OBO) PRIME THERAPEUTICS via HOOPER, LUNDY & BOOKMAN, P.C.
2023 · second_quarter · Q2
Issues related to PBM Transparency; S. 127, The Pharmacy Benefit Manager Transparency Act of 2023; S. 1339, the Pharmacy Benefit Manager Reform Act; H.R. 3561, The PATIENT Act; H.R. 3281 The Transparent Price Act.
Issues related to oversight of PBM services; Issues related to utilization of real-time benefit checks; S. 1967, Patients Before Middlemen Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF DENTAL PLANS via HOOPER, LUNDY & BOOKMAN, P.C.
2023 · second_quarter · Q2
H.R. 1342, Medicaid Dental Benefit Act of 2023; Issues related to expanding access to dental benefits.
H.R. 1671, Increasing Access to Dental Insurance Act; Issues related to operation of the Affordable Care Act Exchanges; Issues related to expanding access to dental benefits.
H.R. 1385, DOC Access Act of 2023.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ROCHE DIAGNOSTICS CORPORATION via HOOPER, LUNDY & BOOKMAN, P.C.
2023 · second_quarter · Q2
H.R. 2369 The Verifying Leading-edge IVCT Development Act.
S.1000 / H.R. 1835 Saving Access to Laboratory Services Act (SALSA).
Issues related to clinical diagnostic laboratory services; Issues related to public health emergency preparedness; H.R. 2369 The Verifying Leading-edge IVCT Development Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR BEHAVIORAL HEALTHCARE via HOOPER, LUNDY & BOOKMAN, P.C.
2023 · second_quarter · Q2
Issues related to behavioral health care; Issues related to workforce shortages; Issues related to substance use; Issues related to telehealth flexibilities; H.R. 4531, SUPPORT for Patients and Communities Reauthorization Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GOVERNMENT COUNSEL, LLC (OBO) PRIME THERAPEUTICS via HOOPER, LUNDY & BOOKMAN, P.C.
2023 · first_quarter · Q1
Issues relating to prescription benefit manager transparency; S.127 Pharmacy Benefit Manager Transparency Act of 2023.
Issues related to oversight of pharmacy benefit manager services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF DENTAL PLANS via HOOPER, LUNDY & BOOKMAN, P.C.
2023 · first_quarter · Q1
H.R. 1671, Increasing Access to Dental Insurance Act.
H.R. 1385, DOC Access Act of 2023.
H.R. 1342, Medicaid Dental Benefit Act of 2023.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ROCHE DIAGNOSTICS CORPORATION via HOOPER, LUNDY & BOOKMAN, P.C.
2023 · first_quarter · Q1
S.1000 / HR 1835 Saving Access to Laboratory Services Act (SALSA).
Issues related to clinical diagnostic laboratory services; issues related to public health emergency preparedness; H.R. 2369 The Verifying Leading-edge IVCT Development Act.
H.R. 2369 The Verifying Leading-edge IVCT Development Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR BEHAVIORAL HEALTHCARE via HOOPER, LUNDY & BOOKMAN, P.C.
2023 · first_quarter · Q1
Issues related to behavioral health care, issues related to workforce shortages, issues related to substance use, issues related to telehealth flexibilities.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GOVERNMENT COUNSEL, LLC (OBO) PRIME THERAPEUTICS via HOOPER, LUNDY & BOOKMAN, P.C.
2022 · fourth_quarter · Q4
Public Law 117-328-Consolidated Appropriations Act, 2023, relating to oversight of PBM services and S.4293 (Pharmacy Benefit Manager Transparency Act of 2022).
Issues related to oversight of PBM services.
S. 4293 Pharmacy Benefit Manager Transparency Act of 2022; H.R. 7666: "The Restoring Hope for Mental Health and Well-Being Act of 2022," Title VI, Sec. 602, Oversight of Pharmacy Benefit Manager Services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ROCHE DIAGNOSTICS CORPORATION via HOOPER, LUNDY & BOOKMAN, P.C.
2022 · fourth_quarter · Q4
H.R. 4128/S. 2209, The Verifying Leading-edge IVCT Development Act of 2021.
H.R. 4128/S. 2209, The Verifying Leading-edge IVCT Development Act of 2021.
Public Law 117-328, the Consolidated Appropriations Act, 2023, relating to Medicare payment rates for clinical diagnostic laboratory services (H.R. 8188/S. 4449 - SALSA) and regulation of laboratory developed tests (FDASLA Act of 2022).
NATIONAL ASSOCIATION OF DENTAL PLANS via HOOPER, LUNDY & BOOKMAN, P.C.
2022 · fourth_quarter · Q4
S. 1793/H.R. 3461 the DOC Access Act of 2021".
S. 4739/H.R. 9567 the Increasing Access to Dental Insurance Act.
Issues related to the provision of dental benefits under the Medicare program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR BEHAVIORAL HEALTHCARE via HOOPER, LUNDY & BOOKMAN, P.C.
2022 · fourth_quarter · Q4
The Mental Health Access Improvement Act (S. 828/H.R. 432); The Medicaid Reentry Act of 2021 (S. 285/H.R. 955), Excellence in Mental Health and Addiction Treatment Act of 2021 (S. 2069/H.R. 4323); issues related to workforce shortages, issues related to opioid use/overdose, issues related to telehealth flexibilities.
Funding for behavioral health organizations; Issues related to workforce shortages, Issues related to opioid use/overdose, Issues related to telehealth flexibilities.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GOVERNMENT COUNSEL, LLC (OBO) PRIME THERAPEUTICS via HOOPER, LUNDY & BOOKMAN, P.C.
2022 · third_quarter · Q3
S. 4293 Pharmacy Benefit Manager Transparency Act of 2022; S. 1388, Prescription Pricing for the People Act; S. 3700/H.R. 6833, Affordable Insulin Now Act; draft legislation The Improving Needed Safeguards for Users of Lifesaving Insulin Now Act."
Issues related to Medicare Part D beneficiary cost-sharing, reporting and audit requirements, oversight of PBM services and government negotiated drug pricing; the Contract Year 2023 Policy and Technical changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs (CMS-4192-P); issues relating to pharmacy direct and indirect remuneration; S. 3700/H.R. 6833, Affordable Insulin Now Act; draft legislation The Improving Needed Safeguards for Users of Lifesaving Insulin Now Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF DENTAL PLANS via HOOPER, LUNDY & BOOKMAN, P.C.
2022 · third_quarter · Q3
Policies related to operation of the Affordable Care Act Exchanges, including enrollment functions, and independent purchase of dental benefits. Policies related to increased affordability of ACA coverage, including expanded availability of premium tax credits. S. 4739, the Increasing Access to Dental Insurance Act.
DOC Access Act of 2021 (S. 1793/H.R. 3461); Issues related to dental care and benefits; Issues related to teledentistry.
The Medicaid Dental Benefits Act (S. 3166/H.R. 4439); Medicare coverage of medically necessary oral and dental treatments; Issues related to the provision of dental benefits under the Medicare program; Issues related to dental care and benefits.
ROCHE DIAGNOSTICS CORPORATION via HOOPER, LUNDY & BOOKMAN, P.C.
2022 · third_quarter · Q3
S. 3799-PREVENT Pandemics Act.
Issues relating to COVID diagnostic testing; H.R. 747/S.1018-Access to TESTs Act; H.R. 3463/S. 1693-Medical Supplies for Pandemics Act of 2021; S.1974-Strengthening America's Strategic National Stockpile Act of 2021; S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, H.R. 7667, the "Food and Drug Amendments of 2022"; H.R. 4128/S. 2209; S. 4348 Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act of 2022; The Verifying Accurate Leading-edge IVCT Development Act of 2021; Issues related to public health emergency preparedness.
ASSOCIATION FOR BEHAVIORAL HEALTHCARE via HOOPER, LUNDY & BOOKMAN, P.C.
2022 · third_quarter · Q3
The Mental Health Access Improvement Act (S. 828/H.R. 432); The Medicaid Reentry Act of 2021 (S. 285/H.R. 955), Excellence in Mental Health and Addiction Treatment Act of 2021 (S. 2069/H.R. 4323);Issues related to workforce shortages; Issues related to opioid use/overdose; Issues related to telehealth flexibilities.
Funding for behavioral health organizations; Issues related to workforce shortages; Issues related to opioid use/overdose; Issues related to telehealth flexibilities.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ROCHE DIAGNOSTICS CORPORATION via HOOPER, LUNDY & BOOKMAN, P.C.
2022 · second_quarter · Q2
H.R. 4128/S.2209, the Verifying Accurate Leading-edge IVCT Development Act of 2021 (the VALID Act of 2021).
S. 3799-PREVENT Pandemics Act.
Issues relating to COVID diagnostic testing; H.R. 747/S.1018-Access to TESTs Act; H.R. 3463/S. 1693-Medical Supplies for Pandemics Act of 2021; S.1974-Strengthening America's Strategic National Stockpile Act of 2021; S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, H.R. 7667, the "Food and Drug Amendments of 2022".
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF DENTAL PLANS via HOOPER, LUNDY & BOOKMAN, P.C.
2022 · second_quarter · Q2
Policies related to operation of the Affordable Care Act Exchanges, including enrollment functions, and independent purchase of dental benefits. Policies related to increased affordability of ACA coverage, including expanded availability of premium tax credits.
The Medicaid Dental Benefits Act (S. 3166/H.R. 4439); Medicare coverage of medically necessary oral and dental treatments; Issues related to the provision of dental benefits under the Medicare program; Issues related to dental care and benefits.
DOC Access Act of 2021 (S. 1793/H.R. 3461); Issues related to dental care and benefits; Issues related to teledentistry.
ASSOCIATION FOR BEHAVIORAL HEALTHCARE via HOOPER, LUNDY & BOOKMAN, P.C.
2022 · second_quarter · Q2
Funding for behavioral health organizations; Issues related to workforce shortages; Issues related to opioid use/overdose; Issues related to telehealth flexibilities.
The Mental Health Access Improvement Act (S. 828/H.R. 432); The Medicaid Reentry Act of 2021 (S. 285/H.R. 955), Excellence in Mental Health and Addiction Treatment Act of 2021 (S. 2069/H.R. 4323);Issues related to workforce shortages; Issues related to opioid use/overdose; Issues related to telehealth flexibilities.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GOVERNMENT COUNSEL, LLC (OBO) PRIME THERAPEUTICS via HOOPER, LUNDY & BOOKMAN, P.C.
2022 · second_quarter · Q2
Issues related to Medicare Part D beneficiary cost-sharing, reporting and audit requirements, oversight of PBM services and government negotiated drug pricing; the Contract Year 2023 Policy and Technical changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs (CMS-4192-P); issues relating to pharmacy direct and indirect remuneration; S. 2938, The Bipartisan Safer Communities Act of 2022, related to the rebate rule; S. 3700/H.R. 6833, Affordable Insulin Now Act; draft legislation The Improving Needed Safeguards for Users of Lifesaving Insulin Now Act".
HCR: S. 2938, The Bipartisan Safer Communities Act of 2022, related to the rebate rule; S. 4293 Pharmacy Benefit Manager Transparency Act of 2022; S. 1388, Prescription Pricing for the People Act; S. 3700/H.R. 6833, Affordable Insulin Now Act; draft legislation The Improving Needed Safeguards for Users of Lifesaving Insulin Now Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GOVERNMENT COUNSEL, LLC (OBO) PRIME THERAPEUTICS via HOOPER, LUNDY & BOOKMAN, P.C.
2022 · first_quarter · Q1
Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees (RIN: 0936-AA080).
Issues related to Medicare Part D beneficiary cost-sharing, reporting and audit requirements, oversight of PBM services and government negotiated drug pricing; the Contract Year 2023 Policy and Technical changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs (CMS-4192-P) Proposed Rule relating to pharmacy direct and indirect remuneration.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF DENTAL PLANS via HOOPER, LUNDY & BOOKMAN, P.C.
2022 · first_quarter · Q1
DOC Access Act of 2021 (S. 1793/H.R. 3461).
Policies related to operation of the Affordable Care Act Exchanges, including enrollment functions, and independent purchase of dental benefits. Policies related to increased affordability of ACA coverage, including expanded availability of premium tax credits.
The Medicaid Dental Benefits Act (S. 3166/H.R. 4439).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ROCHE DIAGNOSTICS CORPORATION via HOOPER, LUNDY & BOOKMAN, P.C.
2022 · first_quarter · Q1
H.R. 4128/S.2209, the Verifying Accurate Leading-edge IVCT Development Act of 2021 (the VALID Act of 2021).
Issues relating to COVID diagnostic testing; H.R. 747/S.1018-Access to TESTs Act; H.R. 3463/S. 1693-Medical Supplies for Pandemics Act of 2021; S.1974-Strengthening America's Strategic National Stockpile Act of 2021.
S. 3799-PREVENT Pandemics Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR BEHAVIORAL HEALTHCARE via HOOPER, LUNDY & BOOKMAN, P.C.
2022 · first_quarter · Q1
The Mental Health Access Improvement Act (S. 828/H.R. 432); The Medicaid Reentry Act of 2021 (S. 285/H.R. 955), Excellence in Mental Health and Addiction Treatment Act of 2021 (S. 2069/H.R. 4323).
Funding for behavioral health organizations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GOVERNMENT COUNSEL, LLC (OBO) PRIME THERAPEUTICS via HOOPER, LUNDY & BOOKMAN, P.C.
2021 · fourth_quarter · Q4
H.R. 5376 - Build Back Better Act relating to government negotiated drug pricing, Medicare Part D beneficiary cost-sharing, reporting and audit requirements; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees (RIN: 0936-AA080); S. 2327 - Seniors Prescription Drug Relief Act; Issues related to Medicare Part D pharmacy direct and indirect remuneration.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF DENTAL PLANS via HOOPER, LUNDY & BOOKMAN, P.C.
2021 · fourth_quarter · Q4
Build Back Better Act (H.R. 5376), policies related to the provision of dental benefits under the Medicare program; the Medicare Dental Benefit Act of 2021 (HR 502/S 97), the Medicaid Dental Benefits Act (S. 3166), the Medicaid Dental Benefit Act (H.R. 4439).
DOC Access Act of 2021 (S. 1793/H.R. 3461).
Policies related to operation of the Affordable Care Act Exchanges, including enrollment functions, independent purchase of dental benefits, and a special enrollment period.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ROCHE DIAGNOSTICS CORPORATION via HOOPER, LUNDY & BOOKMAN, P.C.
2021 · fourth_quarter · Q4
Verifying Accurate Leading-edge IVCT Development (VALID) Act.
Issues relating to COVID diagnostic testing; H.R. 747 and S.1018-Access to TESTs Act; H.R. 3463 and S. 1693-Medical Supplies for Pandemics Act of 2021; S.1974-Strengthening America's Strategic National Stockpile Act of 2021.
Issues relating to Medicare clinical laboratory fee schedule payment reductions and data reporting (S.610-Protecting Medicare and American Farmers from Sequester Cuts Act).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR BEHAVIORAL HEALTHCARE via HOOPER, LUNDY & BOOKMAN, P.C.
2021 · fourth_quarter · Q4
The Mental Health Access Improvement Act (S. 828/H.R. 432); The Medicaid Reentry Act of 2021 (S. 285/H.R. 955), Excellence in Mental Health and Addiction Treatment Act of 2021 (S. 2069/H.R. 4323).
Funding for behavioral health organizations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS KABI, LLC via HOOPER, LUNDY & BOOKMAN, P.C.
2021 · fourth_quarter · Q4
Policies to incentivize biosimilars and coding, Medicare Rx Price Negotiation Impact on Biosimilars in Build Back Better Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FRESENIUS KABI, LLC via HOOPER, LUNDY & BOOKMAN, P.C.
2021 · third_quarter · Q3
Policies to incentivize biosimilars and coding.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GOVERNMENT COUNSEL, LLC (OBO) PRIME THERAPEUTICS via HOOPER, LUNDY & BOOKMAN, P.C.
2021 · third_quarter · Q3
H.R. 5376 - Build Back Better Act relating to government negotiated drug pricing and Medicare Part D beneficiary cost-sharing; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees (RIN: 0936-AA080); S. 2327 - Seniors Prescription Drug Relief Act; Issues related to Medicare Part D pharmacy direct and indirect remuneration.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF DENTAL PLANS via HOOPER, LUNDY & BOOKMAN, P.C.
2021 · third_quarter · Q3
DOC Access Act of 2021 (S. 1793/H.R. 3461).
Policies related to operation of the Affordable Care Act Exchanges, including enrollment functions, independent purchase of dental benefits, and a special enrollment period.
Build Back Better Act (H.R. 5376), policies related to the provision of dental benefits under the Medicare program; the Medicare Dental Benefit Act of 2021 (HR 502/S 97).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ROCHE DIAGNOSTICS CORPORATION via HOOPER, LUNDY & BOOKMAN, P.C.
2021 · third_quarter · Q3
The Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021 (HR 4128/S 2209).
The Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021 (HR 4128/S 2209); The Access to TESTs Act (HR 747/S1018); The Medical Supplies for Pandemics Act of 2021 (HR 3463/S 1693); The Strengthening Americas Strategic National Stockpile Act of 2021 (S. 1974).
Medicare payment for clinical laboratories and diagnostic tests.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR BEHAVIORAL HEALTHCARE via HOOPER, LUNDY & BOOKMAN, P.C.
2021 · third_quarter · Q3
The Mental Health Access Improvement Act (S. 828/H.R. 432); Medicare coverage of addiction treatment.
Funding for behavioral health organizations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GOVERNMENT COUNSEL, LLC (OBO) PRIME THERAPEUTICS via HOOPER, LUNDY & BOOKMAN, P.C.
2021 · second_quarter · Q2
Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees (RIN: 0936-AA080); Issues relating to Medicare Part D beneficiary cost-sharing; H.R. 3 - Elijah. E. Cummings Lower Drug Costs Now Act relating to government drug price negotiation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF DENTAL PLANS via HOOPER, LUNDY & BOOKMAN, P.C.
2021 · second_quarter · Q2
DOC Access Act of 2021 (S. 1793/H.R. 3461).
Policies related to operation of the Affordable Care Act Exchanges, including enrollment functions, independent purchase of dental benefits, and a special enrollment period.
The American Rescue Plan of 2021 (H.R. 1319); Title VI - Providing for Dental, Vision and Hearing Coverage Under the Medicare Program, the Elijah E. Cummings Lowe Drug Costs Now Act (H.R. 3); the Medicare Dental Benefit Act of 2021 (HR 502/S 97), policies related to the provision of dental benefits under the Medicare program.
ROCHE DIAGNOSTICS CORPORATION via HOOPER, LUNDY & BOOKMAN, P.C.
2021 · second_quarter · Q2
Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021" (H.R. 4128/S. 2209).
Issues related to diagnostic testing; "Access to TESTs Act" (H.R. 747/S. 1018); Issues related to inclusion of diagnostics in the Strategic National Stockpile; "United States Innovation and Competition Act of 2021" (S. 1260) relating to the Strategic National Stockpile; "Medical Supplies for Pandemics Act of 2021" (H.R. 3463/S. 1693).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR BEHAVIORAL HEALTHCARE via HOOPER, LUNDY & BOOKMAN, P.C.
2021 · second_quarter · Q2
Funding for behavioral health organizations.
The Mental Health Access Improvement Act (S. 828/H.R. 432); Medicare coverage of addiction treatment.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS KABI, LLC via HOOPER, LUNDY & BOOKMAN, P.C.
2021 · second_quarter · Q2
Policies to incentivize biosimilars and coding.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF DENTAL PLANS via HOOPER, LUNDY & BOOKMAN, P.C.
2021 · first_quarter · Q1
Policies related to operation of the Affordable Care Act Exchanges, including enrollment functions, independent purchase of dental benefits, and a special enrollment period.
Policies related to the Paycheck Protection Program of the Small Business Act.
DOC Access Act of 2019 (S. 4894/H.R. 3762); Policies related to a limited Special Enrollment Period in the Federally Facilitated Marketplaces and funding for state-based exchanges; Policies related to federal subsidization of COBRA premiums and expansion of Affordable Care Act tax credits (The Concurrent Resolution on the Budget for FY2021 or S. Con. Res 5 and The American Rescue Plan of 2021 (H.R. 1319).
ROCHE DIAGNOSTICS CORPORATION via HOOPER, LUNDY & BOOKMAN, P.C.
2021 · first_quarter · Q1
Medicare payment for clinical laboratories and diagnostic tests.
The Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2020 (HR 6102/S 3404).
Issues related to diagnostic testing; The Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2020 (HR 6102/S 3404); The Access to TESTs Act (HR 747).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR BEHAVIORAL HEALTHCARE via HOOPER, LUNDY & BOOKMAN, P.C.
2021 · first_quarter · Q1
The Mental Health Access Improvement Act (S. 828/H.R. 432).
Funding for behavioral health organizations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GOVERNMENT COUNSEL, LLC (OBO) PRIME THERAPEUTICS via HOOPER, LUNDY & BOOKMAN, P.C.
2021 · first_quarter · Q1
Lower Health Care Costs Act , Section 306 (S. 1895), Consolidated Appropriations Act, 2021 (H.R. 133).
Presidential Executive Order on Lowering Prices for Patients by Eliminating Kickbacks to Middlemen, Issued July 24, 2020; Presidential Executive Order on Lowering Drug Prices by Putting America First, Issued September 13, 2020; Final Rule, Department of Health and Human Services: Office of Inspector General, issued November 20, 2020 entitled Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS KABI, LLC via HOOPER, LUNDY & BOOKMAN, P.C.
2021 · first_quarter · Q1
Policies to Incentivize Biosimilars
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 7148/Public Law No: 119-75, psychedelic therapies for treatment of mental health and substance use disorders related to the FY26 budget for the Department of Health and Human Services; FY2027 budget related to psychedelic therapies for treatment of mental health and substance use disorders.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 3944 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026, funding and report language related to psychedelic research, H.R. 5304/S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026, support for psychedelic therapies for treatment of mental health and substance use disorders.
H.R. 3944 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026, funding and report language related to psychedelic research, H.R.2623 - Innovative Therapies Centers of Excellence Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to a pathway for FDA approval of psychedelic drugs and therapies, issues related to reducing barriers to research and increasing federal funding of clinical research trials for psychedelic drugs and therapies; Issues related to medical adoption of and access to psychedelic drugs and therapies; S. 331 - HALT Fentanyl Act, provisions related to research.
H.R. 3944 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026, funding and report language related to psychedelic research, H.R. 5304/S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026, support for psychedelic therapies for treatment of mental health and substance use disorders.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 3944 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026, funding and report language related to psychedelic research
H.R. 3944 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026, funding and report language related to psychedelic research.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 1385/S. 1424 DOC Access Act of 2023.
H.R. 1342/S. 570 Medicaid Dental Benefit Act of 2023.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 1671/S. 2771 Increasing Access to Dental Insurance Act; Issues related to operation of the Affordable Care Act exchanges, Issues related to expanding access to dental benefits.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
S.4449 / HR 8188 Saving Access to Laboratory Services Act (SALSA).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
S.4449 / HR 8188 Saving Access to Laboratory Services Act (SALSA).
H.R. 4128/S. 2209 The Verifying Accurate Leading-edge IVCT Development Act of 2021.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Policies related to an increase in the Federal Medical Assistance Percentage (FMAP) under section 1905(b) of the Social Security Act, and related to an FMAP increase for dental services; The American Rescue Plan of 2021 (H.R. 1319); Title VI - Providing for Dental, Vision and Hearing Coverage Under the Medicare Program, the Elijah E. Cummings Lowe Drug Costs Now Act (H.R. 3); the Medicare Dental Benefit Act of 2021 (HR 502/S 97).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE